Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF
Clinical trial NCT02808585 · COMPLETED
Trial details
- NCT number
- NCT02808585
- Sponsor
- PhaseBio Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-12-06
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.